[HTML][HTML] Recent applications and strategies in nanotechnology for lung diseases
W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International journal of nanomedicine, 2017 - Taylor & Francis
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
[HTML][HTML] Nanotechnology in respiratory medicine
Like two sides of the same coin, nanotechnology can be both boon and bane for respiratory
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …
New perspectives in nanotherapeutics for chronic respiratory diseases
Abstract According to the World Health Organization (WHO), hundreds of millions of people
of all ages and in all countries suffer from chronic respiratory diseases, with particular …
of all ages and in all countries suffer from chronic respiratory diseases, with particular …
[HTML][HTML] Advances in nanotechnology and asthma
L Wang, M Feng, Q Li, C Qiu, R Chen - Annals of translational …, 2019 - ncbi.nlm.nih.gov
Abstract According to the World Health Organization, Asthma is the fastest-growing disease
in the world alongside HIV/AIDS, and its socioeconomic burden exceeds the sum of …
in the world alongside HIV/AIDS, and its socioeconomic burden exceeds the sum of …
[HTML][HTML] Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses
I Radauer-Preiml, A Andosch, T Hawranek… - Particle and fibre …, 2015 - Springer
Abstract Background Engineered nanomaterials (ENMs) interact with different biomolecules
as soon as they are in contact, resulting in the formation of a biomolecule 'corona'. Hence …
as soon as they are in contact, resulting in the formation of a biomolecule 'corona'. Hence …
Clinical use of adjuvants in allergen-immunotherapy
L Klimek, CB Schmidt-Weber, MF Kramer… - Expert review of …, 2017 - Taylor & Francis
ABSTRACT Introduction: Allergen-specific Immunotherapy (AIT) is the only available
treatment aimed to tackle the underlying causes of allergy. The active components of …
treatment aimed to tackle the underlying causes of allergy. The active components of …
Nanotechnology-based therapeutics for targeting inflammatory lung diseases
The physiochemical properties of drugs used in treating inflammation-associated lung
diseases (ie, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis) play an …
diseases (ie, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis) play an …
Nanoparticle-based drug delivery for chronic obstructive pulmonary disorder and asthma: Progress and challenges
R Wadhwa, T Aggarwal, N Thapliyal… - … in modern animal …, 2019 - Elsevier
Pulmonary diseases including chronic obstructive pulmonary disease (COPD) and asthma
affect millions of people all over the world. Conventional treatment methodologies are not …
affect millions of people all over the world. Conventional treatment methodologies are not …
The use of adjuvants for enhancing allergen immunotherapy efficacy
J Chesné, CB Schmidt-Weber… - … and Allergy Clinics, 2016 - immunology.theclinics.com
Allergic diseases are characterized by the seasonally recurring production of T helper 2
(TH2) cytokines (eg, Interleukin [IL]-4, IL-5, and IL-13), which drive the production of allergen …
(TH2) cytokines (eg, Interleukin [IL]-4, IL-5, and IL-13), which drive the production of allergen …